Sera Prognostics, Inc. (SERA)
$2.07+1.47%Close
SELLRECOVERY · day 48
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $79M
- Beta
- 1.06
- P/E (TTM)
- -3.09
- Short % float
- 0.84%
- Days to cover
- 13.4
- SI change
- +7.4%
- 1W
- +0.00%
- 1M
- +4.02%
- vs SPY 1W
- +0.98%
- vs SPY 1M
- +2.16%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS & VALIDATION
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 2
- GROWTH
- 2
- GARP
- 3
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-28.0%
REV YoY-
ROE-46.7%
EPS YoY-
ROA-38.3%
GROSS-150
OP-53283
NET-47476
[VALUATION]
P/E TTM-3.09
P/E FWD-
SECTOR PE20.48
INDUSTRY PE22.31
P/B1.76
P/FCF-
EV/EBITDA-2.40
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E5.05
ALTMAN Z-
CURR RATIO1.98
ND/EBITDA-
BETA1.06
[BEST COMBO]VALIDATED · V5
ENTER · HOLD · EXIT · WAITOne next-open action from five signal families, published only when the held-out edge survives 20 bps costs.
Today's action with its out-of-fold profit factor, trade count and family votes.
[WHITE ARROW]FULL HISTORY
SELL
Directional consensus stays BUY or SELL until the model reverses; trades fill next session open.
PROFIT FACTOR2.8
TRADES23
[REGIME]FULL HISTORY
RECOVERY
BULL or RECOVERY stays invested; BEAR or CRISIS exits at the next session open.
Profit factor and trade count for holding this symbol only in BULL or RECOVERY.
[EXHAUSTION]NOW
Whether buyers or sellers are stretched today, the latest release and its strength.
Company news
FAQ
- What is LOPJLB’s current signal on SERA?
- LOPJLB’s latest quantitative signal on Sera Prognostics, Inc. (SERA) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is SERA in?
- Sera Prognostics, Inc. (SERA) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Sera Prognostics, Inc. (SERA) do?
- Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally,…